San Mateo, CA, United States of America

Amy Catherine Lee

This inventor holds 34 USPTO granted patents and 6 published patent applications and 7 EPO patents, primarily in Graft Systems. Top assignees: Nellix, Inc., Endologix, Inc., Salesforce Com, Inc.. Active years: 2010-2025.

USPTO Granted Patents = 34 

% Patents Active = 70.6

 

Average Co-Inventor Count = 2.3

ph-index = 12

Forward Citations = 620(Granted Patents)


Location History:

  • Mountain View, CA (US) (2010 - 2012)
  • San Mateo, CA (US) (2013 - 2021)
  • Sunnyvale, CA (US) (2010 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Self-Sealing Tubular Grafts
Aneurysm Treatment
Filling Structures
Scaffolds
Catheter Guiding
Digital Imaging
Sensor Data Gathering
Multilayered Films
User Interface
Automated Audio Generation
Endovascular Systems
34 patents (USPTO):Explore Patents

Title: Inventor Amy Catherine Lee - Revolutionizing Technology

Introduction: Amy Catherine Lee is a pioneering inventor based in San Mateo, CA, known for her groundbreaking contributions to the tech industry.

Latest Patents: Amy Catherine Lee holds several patents in the field of artificial intelligence and machine learning, with her most recent patent focusing on advanced algorithms for data analysis.

Career Highlights: With a career spanning over two decades, Amy Catherine Lee has worked with top tech companies, leading research institutions, and universities to develop cutting-edge technologies that have reshaped the industry.

Collaborations: Throughout her career, Amy Catherine Lee has collaborated with renowned scientists, engineers, and innovators, fostering a culture of innovation and creativity in all her projects.

Conclusion: Amy Catherine Lee's passion for innovation and her relentless drive to push the boundaries of technology make her a true trailblazer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…